Autoimmune Myasthenia Gravis: Emerging Clinical and Biological Heterogeneity

The Lancet Neurology - United Kingdom
doi 10.1016/s1474-4422(09)70063-8
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Elsevier BV

Related search

Ephedrine Treatment for Autoimmune Myasthenia Gravis

Neuromuscular Disorders
Child HealthNeurologyPediatricsPerinatologyGenetics
2017English

New Pathways and Therapeutic Targets in Autoimmune Myasthenia Gravis

Journal of Neuromuscular Diseases
Neurology
2018English

Complicating Autoimmune Diseases in Myasthenia Gravis: A Review

Autoimmunity
AllergyImmunology
2015English

The Emerging Role of Tacrolimus in Myasthenia Gravis

Therapeutic Advances in Neurological Disorders
NeurologyPharmacology
2015English

Immunosuppression of Experimental Autoimmune Myasthenia Gravis by Mycophenolate Mofetil

Journal of Neuroimmunology
AllergyImmunologyNeurology
2008English

Myasthenia Gravis

CMAJ
Medicine
2018English

Myasthenia Gravis

Postgraduate Medical Journal
Medicine
1965English

Myasthenia Gravis

Seminars in Neurology
Neurology
2016English

Myasthenia Gravis

JAMA - Journal of the American Medical Association
Medicine
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy